Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Marzia Cavalli"'
Autor:
Giovanni Manfredi Assanto, Ilaria Del Giudice, Irene Della Starza, Roberta Soscia, Marzia Cavalli, Mattia Cola, Vittorio Bellomarino, Mariangela Di Trani, Anna Guarini, Robin Foà
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Minimal/measurable residual disease (MRD) monitoring is progressively changing the management of hematologic malignancies. The possibility of detecting the persistence/reappearance of disease in patients in apparent clinical remission offers a refine
Externí odkaz:
https://doaj.org/article/154cdd8a16554ff688943c29eaa258df
Autor:
Barbara Mantoan, Elisa Genuardi, Martina Ferrante, Irene Della Starza, Elena Ciabatti, Susanna Grassi, Lucia Anna De Novi, Marzia Cavalli, Claudia Mannu, Anna Gazzola, Riccardo Bomben, Massimo Degan, Beatrice Alessandria, Christiane Pott, Marie-Hélène Delfau-Larue, Ramon García-Sanz, Claudio Agostinelli, Valter Gattei, Sara Galimberti, Ilaria Del Giudice, Gianluca Gaidano, Marco Ladetto, Simone Ferrero, Daniela Drandi, on behalf of the Fondazione Italiana Linfomi (FIL) MRD Network
Publikováno v:
HemaSphere, Vol 5, Iss 10, p e639 (2021)
Externí odkaz:
https://doaj.org/article/c844f78f3aab4309b3353b02acdc6983
Autor:
Irene Della Starza, Vittorio Nunes, Federica Lovisa, Daniela Silvestri, Marzia Cavalli, Andrea Garofalo, Mimma Campeggio, Lucia Anna De Novi, Roberta Soscia, Carlotta Oggioni, Lara Mussolin, Andrea Biondi, Anna Guarini, Maria Grazia Valsecchi, Valentino Conter, Alessandra Biffi, Giuseppe Basso, Robin Foà, Giovanni Cazzaniga
Publikováno v:
HemaSphere, Vol 5, Iss 3, p e543 (2021)
Minimal residual disease (MRD) is the most powerful prognostic factor in pediatric acute lymphoblastic leukemia (ALL). Real-time quantitative polymerase chain reaction (RQ-PCR) represents the gold standard for molecular MRD assessment and risk-based
Externí odkaz:
https://doaj.org/article/b1b6d3f45e824146b248f9d4d86c5d5c
Autor:
Sabina Chiaretti, Monica Messina, Irene Della Starza, Alfonso Piciocchi, Luciana Cafforio, Marzia Cavalli, Akram Taherinasab, Michela Ansuinelli, Loredana Elia, Guglielmo Albertini Petroni, Roberta La Starza, Martina Canichella, Alessia Lauretti, Maria Cristina Puzzolo, Valentina Pierini, Alessandra Santoro, Orietta Spinelli, Valerio Apicella, Saveria Capria, Francesco Di Raimondo, Paolo De Fabritiis, Cristina Papayannidis, Anna Candoni, Roberto Cairoli, Marco Cerrano, Nicola Fracchiolla, Daniele Mattei, Chiara Cattaneo, Antonella Vitale, Enrico Crea, Paola Fazi, Cristina Mecucci, Alessandro Rambaldi, Anna Guarini, Renato Bassan, Robin Foà
Publikováno v:
Haematologica, Vol 106, Iss 6 (2020)
Early recognition of Ph-like acute lymphoblastic leukemia cases could impact on the management and outcome of this subset of B-lineage ALL. To assess the prognostic value of the Ph-like status in a pediatric-inspired, minimal residual disease (MRD)-d
Externí odkaz:
https://doaj.org/article/ed0b468b3a894e24aa4dee704c6cc2bc
Autor:
Irene Della Starza, Sabina Chiaretti, Maria S. De Propris, Loredana Elia, Marzia Cavalli, Lucia A. De Novi, Roberta Soscia, Monica Messina, Antonella Vitale, Anna Guarini, Robin Foà
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Introduction: Acute lymphoblastic leukemia (ALL) is the first neoplasm where the assessment of early response to therapy by minimal residual disease (MRD) monitoring has proven to be a fundamental tool to guide therapeutic choices. The most standardi
Externí odkaz:
https://doaj.org/article/21657571b4ce4cab9b5e2eabb05bf5e4
Autor:
Ilaria Del Giudice, Sara Raponi, Irene Della Starza, Maria Stefania De Propris, Marzia Cavalli, Lucia Anna De Novi, Luca Vincenzo Cappelli, Caterina Ilari, Luciana Cafforio, Anna Guarini, Robin Foà
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
In chronic lymphocytic leukemia (CLL), there is a growing interest for minimal residual disease (MRD) monitoring, due to the availability of drug combinations capable of unprecedented complete clinical responses. The standardized and most commonly ap
Externí odkaz:
https://doaj.org/article/fa5f62d28d884ff996c650c825cb3068
Autor:
Roberta Soscia, Irene Della Starza, Lucia Anna De Novi, Caterina Ilari, Michela Ansuinelli, Marzia Cavalli, Vittorio Bellomarino, Luciana Cafforio, Mariangela Di Trani, Giovanni Cazzaniga, Grazia Fazio, Alessandra Santoro, Domenico Salemi, Orietta Spinelli, Manuela Tosi, Carolina Terragna, Valentina Robustelli, Teresa Bellissimo, Gioia Colafigli, Massimo Breccia, Sabina Chiaretti, Alice Di Rocco, Maurizio Martelli, Anna Guarini, Ilaria Del Giudice, Robin Foà
Publikováno v:
Hematological Oncology. 41:50-60
Circulating tumor DNA (ctDNA) has become the most investigated analyte in blood. It is shed from the tumor into the circulation and represents a subset of the total cell-free DNA (cfDNA) pool released into the peripheral blood. In order to define if
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab445f1a9f32cd726623ef4c9ec3335
https://doi.org/10.1002/hon.3087
https://doi.org/10.1002/hon.3087
Autor:
Massimo Federico, Mario Petrini, Pellegrino Musto, Gianluca Gaidano, Giovanni Bertoldero, Daniele Vallisa, Carola Boccomini, Umberto Vitolo, Alessandro Pulsoni, Luigi Rigacci, Giuseppe Alberto Palumbo, Alessandra Tucci, Luca Arcaini, Marzia Cavalli, Irene Della Starza, Ilaria Del Giudice, Barbara Mantoan, Luigia Monitillo, Claudia Mannu, Anna Gazzola, Pier Paolo Piccaluga, Marco Ladetto, Luigi Marcheselli, Alessandra Dondi, Francesca Guerrini, Susanna Grassi, Elena Ciabatti, Stefano Luminari, Sara Galimberti
Cox proportional hazard Models for PFS: role of MRD-negativity after 12 month of follow-up.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53851273584ac713f26f61c5ea2144f4
https://doi.org/10.1158/1078-0432.22459337
https://doi.org/10.1158/1078-0432.22459337
Autor:
Massimo Federico, Mario Petrini, Pellegrino Musto, Gianluca Gaidano, Giovanni Bertoldero, Daniele Vallisa, Carola Boccomini, Umberto Vitolo, Alessandro Pulsoni, Luigi Rigacci, Giuseppe Alberto Palumbo, Alessandra Tucci, Luca Arcaini, Marzia Cavalli, Irene Della Starza, Ilaria Del Giudice, Barbara Mantoan, Luigia Monitillo, Claudia Mannu, Anna Gazzola, Pier Paolo Piccaluga, Marco Ladetto, Luigi Marcheselli, Alessandra Dondi, Francesca Guerrini, Susanna Grassi, Elena Ciabatti, Stefano Luminari, Sara Galimberti
Purpose: The role of the minimal residual disease (MRD) in follicular lymphoma is still debated. In this study, we assessed whether the BCL2/IGH rearrangement could have a prognostic role in patients receiving R-CHOP, R-FM, or R-CVP.Experimental Desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ce70ec1391d4091e58b90eef2f5b9e
https://doi.org/10.1158/1078-0432.c.6524198
https://doi.org/10.1158/1078-0432.c.6524198
Autor:
Massimo Federico, Mario Petrini, Pellegrino Musto, Gianluca Gaidano, Giovanni Bertoldero, Daniele Vallisa, Carola Boccomini, Umberto Vitolo, Alessandro Pulsoni, Luigi Rigacci, Giuseppe Alberto Palumbo, Alessandra Tucci, Luca Arcaini, Marzia Cavalli, Irene Della Starza, Ilaria Del Giudice, Barbara Mantoan, Luigia Monitillo, Claudia Mannu, Anna Gazzola, Pier Paolo Piccaluga, Marco Ladetto, Luigi Marcheselli, Alessandra Dondi, Francesca Guerrini, Susanna Grassi, Elena Ciabatti, Stefano Luminari, Sara Galimberti
Supplemental Figure Legend from Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cac070f6d8146657c73c5388c8ecc568
https://doi.org/10.1158/1078-0432.22459328
https://doi.org/10.1158/1078-0432.22459328